Expression of relaxin-like factor is down-regulated in human testicular Leydig cell neoplasia

• Published in: Molecular human reproduction Vol. 5; no. 2; pp. 104 - 108
• Main Authors: KLONISCH, T, IVELL, R, BALVERS, M, KLIESCH, S, FISCHER, B, BERGMANN, M, STEGER, K
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 01.02.1999
• Subjects: Adenoma - genetics; Adenoma - metabolism; Adult; Aged; Biological and medical sciences; Down-Regulation; Fundamental and applied biological sciences. Psychology; Gene expression; Humans; Hyperplasia - genetics; Hyperplasia - metabolism; Immunohistochemistry; In Situ Hybridization; Insulin; Leydig Cells - metabolism; Leydig Cells - pathology; Male; Middle Aged; Molecular and cellular biology; Molecular genetics; Polymerase Chain Reaction - methods; Proteins - genetics; Proteins - metabolism; Testicular Neoplasms - genetics; Testicular Neoplasms - metabolism; Human; Immunohistochemistry; Molecular hybridization; Adenoma; Testicle; Male genital system; Relaxin; Ovarian hormone; Leydig cell; Regulation(control); Messenger RNA; Benign neoplasm; Molecular cloning; Tumor cell
• ISSN: 1360-9947; 1460-2407; 1460-2407
• DOI: 10.1093/molehr/5.2.104

In addition to their role in steroidogenesis in the male, testicular Leydig cells constitutively express large amounts of the peptide relaxin-like factor (RLF), also known as Ley-IL. The Leydig cell-derived RLF belongs to the insulin-like superfamily, which also includes relaxin, insulin and the insulin-like growth factors, and within the testis is a specific marker of Leydig cells. Little information is available either on the regulation of gene expression or on the function of this Leydig cell-derived peptide. In the present study we have investigated the expression pattern of human RLF in patients with rare Leydig cell hyperplasia and adenoma. The expression of both mRNA and protein appear to be decreased in hyperplastic Leydig cells, whereas in the Leydig cell adenomas studied, large central areas of the adenoma were devoid of RLF mRNA and protein. Only Leydig cells located at the periphery of the adenoma displayed expression of RLF, with full agreement between in-situ hybridization and immunohistochemistry. It thus appears that the expression of the RLF gene and its products are down-regulated in Leydig cell hyperplasia and adenoma, consistent with a concomitant dedifferentiation of these cells.